SEA Health Tech Investment Insights

Future Targets to Watch Out For INSEAD We've identified the following companies as interesting and a candidate for future investments, but are too early for IFC's investing criteria: Company Founded HQ Latest Funding Health at Home 2015 Thailand bm 2018 Vietnam Seed Round Undisclosed Seed Round April 2020 newman's 2020 Indonesia Seed Round March 2020 2016 Indonesia Seed Round January 2017 TeleCTG Description Health at Home tailors and connects the right caregivers to patients with various ailments and conditions. In addition, Health at Home provides digital consultations and care management. BuyMed offers a platform to centralize the pharmaceutical distribution network in Vietnam, matching supply and demand of pharmaceuticals and commercial health items. Newman's is a Y-Combinator backed digital health clinic for men focusing on hair loss, sexual health, and smoking addiction. The platform provides access to doctor consultations and prescriptions. TeleCTG develops cardiotocography device that detects fetal heartbeat in the womb. The device is affordable enough to be purchased by rural medical workers, so abnormalities can be detected more quickly and prevent mortality of mothers and babies. Reason Thailand and other SEA countries having an aging population with low/no growth of the younger population. This startup's services will be in demand as the aging population requires more in-home care. BuyMed is backed by Sequoia Capital India's Surge early- stage accelerator, and has reported large growth in its annual revenue in the past year. It already has an immense number of verified suppliers, distributors, manufacturers, and healthcare providers on its platform. We see a huge potential for growth with new product lines and further expansion into various SEA markets. This digital health startup is tackling a niche market in Indonesia that is stigmatized in the region, allowing men to address some of these issues without having to be embarrassed to seek treatment. We see high growth potential in this niche segment of men's health. Super interesting medical device startup tackling infant and mother mortality with an affordable cardiotocography device. This especially helps rural hospitals with lower accessibility. It's in Phase I clinical trials, and we see a promising future if the it can complete all clinical trials and establish partnerships with governments and hospitals. Note: Further details available in the attached Excel File. 25

View entire presentation